HealthCor logo

HealthCor

North America, New York, United States, New York

Description

HealthCor is an investment management firm that provides accounting, investment and advisory services to the healthcare and life sciences.

Investor Profile

HealthCor has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in France, United States.
  • Strong thematic focus on Biotechnology, Life Science, Health Care.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • France (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HealthCor frequently co-invest with?

Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 1
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 1
HealthCor Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
Columbia Threadneedle Investments
North America, Massachusetts, United States, Boston
Co-Investments: 1
eureKARE
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Coatue
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by HealthCor?

Kyverna Therapeutics

Berkeley, California, United States

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

BiotechnologyLife ScienceTherapeutics
Series BJan 26, 2022
Amount Raised: $85,000,000
DNA Script

Le Kremlin-bicêtre, Ile-de-France, France

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

BiotechnologyHealth CareLife ScienceMedical
Series CJan 4, 2022
Amount Raised: $200,000,000